Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells
/in International Publications, Newcastle Disease VirusModulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice
/in Hyperthermia, International PublicationsAntigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model
/in Dendritic Cells, International Publications, Pancreatic CancerClinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis
/in Dendritic Cells, Glioblastoma, International PublicationsMultimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusThe effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells
/in Hyperthermia, International PublicationsNewcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease VirusRetrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsMitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
/in International Publications, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer